Male pattern hair loss is not one problem. It is two, working at the same time, and understanding that is the key to understanding why the most effective medical approach uses two medications rather than one.

The first driver is hormonal. A byproduct of testosterone called DHT gradually miniaturizes genetically susceptible hair follicles, shrinking them over successive growth cycles until they produce hair that is thinner, shorter, and eventually invisible. The second driver is circulatory and follicular: even follicles that are still viable can be underfed and stuck in a resting state, not actively growing. These are different mechanisms, and treating just one leaves the other untouched.

This is the logic behind combining finasteride and minoxidil, the two most-used and best-supported medications for male pattern hair loss. Finasteride goes after the hormonal driver. Minoxidil goes after the follicular one. Together they cover both fronts of a two-front problem. And in the last few years, one of these treatments, minoxidil, has been quietly transformed by a shift in how it is delivered, from a messy topical foam to a simple daily pill. This article explains the science of both, why the combination makes sense, and the honest reality of what these medications can and cannot do.

The short answer

Male pattern hair loss (androgenetic alopecia) is driven by two things: DHT-mediated follicle miniaturization and inadequate follicular growth activity. Finasteride addresses the first by lowering DHT; minoxidil addresses the second by extending the growth phase of the hair cycle and supporting the follicle. Finasteride 1mg is FDA-approved for male pattern hair loss and reduces scalp DHT substantially. Minoxidil is FDA-approved as a topical, but low-dose oral minoxidil, taken as a daily pill, has rapidly become a mainstream dermatology practice over the past few years, supported by a growing evidence base, because it solves the adherence problem that causes most people to quit the topical. Combining the two addresses both drivers in one daily routine. CLYR's Men's Hair Tablet compounds oral minoxidil 5mg, finasteride 1mg, and zinc into a single once-daily tablet, prescribed after a licensed provider review. The honest caveats: results take three to six months, the combination tablet is compounded (not FDA-approved as a finished product), and both drugs carry real side effects worth understanding.

Front one: DHT and finasteride

The hormonal driver of male pattern hair loss is dihydrotestosterone, or DHT. It is produced when an enzyme called 5-alpha-reductase converts testosterone into DHT, and in men with a genetic susceptibility, DHT binds to receptors in scalp follicles and progressively miniaturizes them. Each growth cycle, the affected follicle gets a little smaller and the hair it produces a little finer, until it stops producing visible hair at all. This is why male pattern hair loss follows its characteristic pattern, the hairline and crown, where follicles are most DHT-sensitive.

Finasteride interrupts this process at the source. It inhibits 5-alpha-reductase (specifically the type II enzyme), which reduces the body's production of DHT. At the standard 1mg daily dose, finasteride lowers serum DHT substantially and scalp DHT by roughly 60%, which slows or halts the miniaturization process and, for many men, allows follicles to recover.

The evidence is strong and long-standing. Finasteride 1mg is FDA-approved for male pattern hair loss, and the approval rests on solid trials. The landmark studies by Kaufman and colleagues, published in the Journal of the American Academy of Dermatology in 1998, showed that over two years, men aged 18 to 41 taking finasteride had increased hair counts, improved appearance ratings from both patients and investigators, and slowed progression of hair loss, while the placebo group continued to lose hair. Five-year extension data confirmed the benefit was maintained with continued use. This is one of the most well-established treatments in all of dermatology.

Finasteride's honest limitation is that it is defensive as much as offensive: it is excellent at stopping further loss and can produce regrowth, but its primary power is halting the hormonal attack. It does nothing for the second driver, the follicle's own growth activity. That is minoxidil's job.

Front two: the follicle and minoxidil

Minoxidil works on an entirely different mechanism, and an interesting one. It was originally an oral blood-pressure medication, and doctors noticed patients taking it grew hair, unexpectedly and sometimes inconveniently. That side effect was reformulated into the topical hair treatment most people know.

Minoxidil's exact mechanism in hair is still not fully understood, but it is believed to work by opening potassium channels and widening blood vessels around the follicle, and, more importantly, by extending the anagen (active growth) phase of the hair cycle. In effect, it pushes resting follicles back into growth and keeps growing follicles growing longer. Where finasteride removes the hormonal brake, minoxidil presses the growth accelerator. The two are genuinely complementary, which is why dermatologists have combined them for decades.

Topical minoxidil is FDA-approved and effective. But it has a fatal practical flaw: adherence. It has to be applied to the scalp once or twice a day, every day, indefinitely. It can leave residue, affect hair styling, cause scalp irritation, and it is simply easy to forget or abandon. Studies and clinical experience consistently find that most people stop using topical minoxidil, often in the first couple of months, right before it would have started working. A treatment you quit is a treatment that does not work.

The shift that changed hair medicine: oral minoxidil

This is the part of the story that is genuinely new, and it is why CLYR's tablet exists in the form it does.

Over the past several years, dermatologists have increasingly prescribed minoxidil orally, as a low-dose daily pill, rather than topically. The doses used for hair (typically 0.625 to 5mg daily) are a small fraction of the 10 to 40mg once used for blood pressure. The logic is compelling: an oral pill bypasses the adherence problem that undermines the topical, avoids scalp irritation entirely, and appears to produce comparable or better results. Taking a pill with your morning routine is something people actually keep doing.

The evidence has caught up with the practice. A 2025 meta-analysis of 27 studies covering 2,933 patients found that low-dose oral minoxidil improved hair growth for many patients and held others stable with no further loss, with the clearest benefit at doses above 1mg per day. Just as importantly, head-to-head randomized trials comparing oral to topical minoxidil found no significant difference in hair density improvement between the two routes, meaning the oral pill delivers topical-level results without the topical's daily hassle.

The shift has been formalized by the field itself. In January 2025, a panel of 43 hair-loss dermatologists from 12 countries published an expert consensus statement in JAMA Dermatology endorsing low-dose oral minoxidil as a treatment option for androgenetic alopecia in adult men and women, and providing dosing guidance. Low-dose oral minoxidil has, in the words of one review, moved from off-label curiosity to evidence-based practice.

The honest disclosure that must accompany this: oral minoxidil for hair loss is prescribed off-label. Its FDA approval is as a blood-pressure drug (oral) and as a topical hair treatment; the low-dose oral use for hair is not an FDA-approved indication, even though it is now widely practiced and well-supported. That is a real and important distinction, and it is exactly the kind of thing an honest provider tells you rather than glosses over.

Why combine them, and why one tablet

Putting the two fronts together: finasteride lowers DHT to stop the hormonal miniaturization, and minoxidil extends the growth phase to feed and revive the follicles. DHT blockade plus growth-phase extension is the standard maximum-medical-therapy approach for men who want the most effective medical treatment, and it is complementary by design, two mechanisms, two drivers, one combined effect. Emerging data on the specific low-dose oral minoxidil plus finasteride combination has reported robust improvements in men with androgenetic alopecia across severity levels, consistent with what the two drugs do individually.

The practical innovation in CLYR's tablet is consolidation. Instead of a topical to apply and a pill to swallow (two products, two routines, two chances to quit), both actives are combined into a single daily tablet, with zinc included as well. The entire regimen becomes one pill with your morning coffee. Given that adherence is the single biggest predictor of whether hair treatment works, collapsing the routine into one daily tablet is not a gimmick, it directly addresses the main reason hair treatments fail.

The zinc in the formulation plays a supporting role. Zinc is a mineral involved in hair tissue growth and repair and in the metabolism of hormones relevant to hair, and zinc deficiency is associated with hair shedding. It is a complementary component rather than a primary driver of results, but it is a sensible inclusion in a hair-focused formulation.

What to realistically expect

Honesty about timeline and expectations is essential with hair treatment, because unrealistic expectations are why people quit before it works.

It is slow. Hair grows on a months-long cycle, and no medication changes that. Most people need three to six months of consistent daily use before they can fairly judge results, and the fuller benefit continues to develop over a year or more.

Early shedding is normal and expected. In the first weeks, many people notice increased shedding. This is counterintuitive and alarming if you do not expect it, but it is usually a sign the treatment is working: minoxidil pushes resting follicles into a new growth phase, which first sheds the old resting hair. It typically settles within a couple of months. Knowing this in advance is important, because this shedding phase is exactly when discouraged people abandon treatment.

It is maintenance, not cure. These medications manage an ongoing genetic and hormonal process. They work while you take them. If you stop, the DHT-driven miniaturization resumes and gains are gradually lost over the following months. This is a long-term commitment, not a course of treatment with an endpoint.

It is better at keeping than regrowing. Both drugs are more reliable at halting loss and thickening existing hair than at regrowing hair from long-dead follicles. Starting earlier, while there is more to preserve, generally produces better outcomes than starting after extensive loss.

Honest safety: both drugs, clearly

Both medications have real, well-characterized side effects, and a responsible account states them plainly.

Finasteride. The concern that gets the most attention is sexual side effects, decreased libido, erectile dysfunction, or ejaculation changes. In the pivotal trials these occurred in roughly 2 to 4% of men versus about 2% on placebo, a small but real difference. Most cases resolve on stopping the drug; there are debated post-marketing reports of persistent symptoms in a small number of men, and the honest position is that this risk appears low but is not zero and is worth discussing with a provider. Finasteride can also affect mood in some men, and it lowers PSA (the prostate cancer screening marker), so any man taking it must tell a doctor ordering a PSA test. Critically, finasteride must not be handled by anyone who is or may become pregnant, because of risk to a male fetus, which is why the tablets should never be crushed or split and should be kept sealed.

Oral minoxidil. Because it started as a blood-pressure drug, its side effects are cardiovascular and fluid-related: it can cause fluid retention and ankle swelling, a faster heartbeat, lightheadedness, and, notably, unwanted hair growth on the face and body (hypertrichosis), which is the most common reason people discontinue. At the low doses used for hair, large safety studies, including a multicenter study of over 1,400 patients, have found low-dose oral minoxidil generally well-tolerated with a lower adverse-effect rate than blood-pressure doses. But the cardiovascular profile is exactly why this is a prescription medication requiring provider screening: anyone with certain heart conditions, low blood pressure, or a recent cardiac event needs careful evaluation, and some people should not take it at all.

This is the core reason hair medication of this kind belongs with a licensed provider rather than a no-questions-asked website. A provider screens blood pressure, cardiac history, and prostate history, confirms the medications are appropriate for you, and monitors for these specific effects. That screening is the safeguard.

How CLYR offers it

CLYR's Men's Hair Tablet combines oral minoxidil 5mg, finasteride 1mg, and zinc in one compounded daily tablet, prescribed only after a licensed U.S. provider reviews your intake, including blood pressure, cardiac history, prostate history, and current medications, and confirms the treatment is appropriate. If it is not appropriate, treatment is declined. The tablet is compounded by a state-licensed 503A pharmacy and shipped as a full 90-tablet supply in one plain, unmarked package, $129 billed once, with no subscription and no auto-renew.

The honest regulatory picture, stated plainly: finasteride 1mg has an FDA-approved single-ingredient product for male pattern hair loss, oral minoxidil is prescribed off-label for hair, and the combined three-active tablet is a compounded preparation that is not itself FDA-approved as a finished product. Compounded medications are prepared by licensed pharmacies based on a provider's judgment and are not FDA-reviewed for safety or effectiveness. The individual actives are established; the convenience is in combining them, and CLYR states that distinction directly.

Frequently asked questions

How is oral minoxidil different from the topical?

Same drug, different delivery. Topical minoxidil is applied to the scalp daily; oral minoxidil is a low-dose daily pill. Head-to-head trials found comparable hair-density results, but the pill avoids scalp irritation and the daily-application hassle that causes most people to quit the topical. Oral minoxidil for hair is prescribed off-label.

Does oral minoxidil actually work?

For many men, yes, in some form. In a large 2025 analysis, many patients saw visible regrowth and many others stopped losing hair, with the clearest benefit at doses above 1mg per day. Results are best when you start earlier and stay consistent, and individual results vary.

Why take finasteride and minoxidil together?

They address the two different drivers of male pattern hair loss. Finasteride lowers DHT to stop follicle miniaturization; minoxidil extends the follicle's growth phase. Using both is the standard maximum-medical-therapy approach and is more effective than either alone.

How long until I see results?

Three to six months of daily use before you can fairly judge, with continued improvement over a year. Increased shedding in the first few weeks is common and usually a sign the treatment is starting to work. Stopping early is the most common reason it fails.

What are the main side effects?

Finasteride can cause sexual side effects (in a small percentage of men) and lowers PSA. Oral minoxidil can cause fluid retention, faster heartbeat, lightheadedness, and unwanted body or facial hair. Both require provider screening; report new swelling, chest symptoms, or shortness of breath promptly.

Is the combination tablet FDA-approved?

No. Finasteride 1mg alone has an FDA-approved product, oral minoxidil is used off-label for hair, and the combined compounded tablet is not FDA-approved as a finished product. It is compounded by a licensed pharmacy under a provider's prescription.

Do I have to keep taking it?

Yes, to maintain results. These medications manage an ongoing hormonal process; if you stop, the gains are gradually lost over the following months. It is a long-term maintenance treatment.

Who should not take it?

Anyone assigned female at birth, anyone with certain recent cardiac events or heart conditions, anyone with prostate cancer or under evaluation for it, and anyone with known allergies to the ingredients. Several other conditions need provider review. The intake screens for these.

The Bottom Line

Male pattern hair loss is a two-front problem, a hormone shrinking follicles and follicles that need to be pushed back into growth, and the most effective medical approach treats both fronts at once. Finasteride handles the hormonal side by lowering DHT, with decades of strong evidence behind it. Minoxidil handles the follicular side, and its shift from a fussy topical to a simple low-dose daily pill has, over just the last few years, become mainstream evidence-based dermatology because it solves the adherence problem that made the topical fail for so many. In the current evidence, low-dose oral minoxidil helps many men regrow hair or stop losing it. Combining it with finasteride in one daily tablet addresses both drivers while collapsing the routine into the single pill people can actually stick with. It is not instant, it is not a cure, and both drugs carry real side effects that warrant provider oversight, but for men who want a genuinely effective, evidence-based approach to hair loss, this is the proven path.

CLYR's Men's Hair Tablet puts both actives, plus zinc, into one daily tablet, prescribed by a licensed provider and shipped as a 90-tablet supply, $129 billed once, with nothing to cancel. Learn more at the Men's Hair Tablet page.

Medical disclaimer

This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. This medication is a compounded prescription containing oral minoxidil, finasteride, and zinc, dispensed only after a licensed provider reviews your history and determines it is appropriate. It is not for anyone assigned female at birth, and finasteride must not be handled by anyone who is or may become pregnant. Oral minoxidil is prescribed off-label for hair loss and can cause fluid retention, rapid heartbeat, low blood pressure, and unwanted hair growth; finasteride can cause sexual side effects and mood changes and lowers PSA. Finasteride 1mg has an FDA-approved single-ingredient product for male pattern hair loss; oral minoxidil's use for hair is off-label; and the combined compounded tablet is not FDA-approved as a finished product, and compounded medications are prepared by licensed pharmacies without FDA review for safety or effectiveness. Results take three to six months and early shedding is expected. The decision to begin any prescription or compounded medication should be made in consultation with a licensed healthcare provider who knows your full medical history and current medications. Individual results vary.